Layani, Sadiya .

HRN: 28-22-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2026
CEFUROXIME 500MG (TAB)
01/28/2026
02/04/2026
PO
500 Mg
BID
S/P NSVD With RMLE
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: